A Look At Daicel (TSE:4202) Valuation As Polyoxymethylene Demand Outlook Improves

Daicel stock in the context of growing polyoxymethylene demand Anticipated growth in the global polyoxymethylene market, supported by demand from automotive, industrial, and electronics sectors, is drawing attention to Daicel (TSE:4202) as a supplier exposed to lightweight and low emission materials. See our latest analysis for Daicel. Daicel’s share price at ¥1,275 has a 1 day share price return of 0.75% and a 7 day share price return of 1.03%. The 30 day and 90 day share price returns of 7.71% and 14.40% indicate that recent momentum has eased, while the 1 year and 5 year total shareholder returns of 13.28% and 85.51% point to stronger longer term participation in the stock’s story. If you are comparing Daicel with other material and industrial names, it can help to widen the lens and review 10 top founder-led companies With Daicel trading at ¥1,275 and indicators such as an intrinsic value gap and a discount to analyst targets in play, the key question is whether this represents a genuine value opportunity or whether the market already reflects expected future growth. Price-to-Earnings of 7.9x: Is it justified? On a P/E of 7.9x at a last close of ¥1,275, Daicel screens as undervalued compared with both its peers and the broader JP Chemicals industry according to the Simply Wall St model. The P/E ratio compares the company’s share price with its earnings per share, so a lower P/E can suggest the market is assigning a cheaper price to each unit of profit than it does for similar companies. For Daicel, the current P/E of 7.9x sits well below the peer average of 15.1x and the JP Chemicals industry average of 14.4x. The estimated fair P/E of 17.1x is also materially higher than where the stock trades today, which points to a level the market could move towards if earnings and cash flow expectations hold and sentiment lines up with sector norms. Explore the SWS fair ratio for Daicel Result: Price-to-Earnings of 7.9x (UNDERVALUED). However, weaker 30 and 90 day returns, together with reliance on cyclical end markets like autos and electronics, could quickly challenge the current value argument. Find out about the key risks to this Daicel narrative. Another view on value from the SWS DCF model The SWS DCF model presents a starker picture, with Daicel trading at ¥1,275 versus an estimated future cash flow value of ¥4,780.72, a discount of 73.3%. That is a large gap. It raises the question of whether the market is too cautious or the model too optimistic. Look into how the SWS DCF model arrives at its fair value. 4202 Discounted Cash Flow as at Apr 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Daicel for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 18 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps The mix of potential value and clear uncertainties around Daicel means opinions will differ. Act promptly, test the assumptions, and weigh up the 3 key rewards and 2 important warning signs. Looking for more investment ideas? If Daicel has caught your attention, do not stop here. Broaden your watchlist with a few focused idea sets that match different investing goals. Target potential mispricings by scanning companies that combine quality with a margin of safety using the 18 high quality undervalued stocks. Strengthen your income stream by reviewing businesses with solid payouts and yields through the 29 dividend fortresses. Prioritize resilience by checking companies that score well on financial strength and stability inside the 52 resilient stocks with low risk scores. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for Free